Note: Ingredients listed on restricted chemical lists
EC/CAS
103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
N/A
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
N/A
EC/CAS
9004-64-2
Name of the chemical
hydroxypropylcellulose
Concentration
N/A
General Information
Revision date
2015-05-31
Product name
XARTEMIS
Product Synonyms
Oxycodone Hydrochloride and Acetaminophen 7.5 mg/325 mg Tablets
1.2.2. Uses advised against
Recommended restrictions
Manufacturer Name
Mallinckrodt
Emergency telephone
314-654-1600
Icons in SDS
Company Information
company name
Mallinckrodt
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
OSHA identification
Physical hazards
Physical hazards Not classified.
Health hazards
Health hazards Acute toxicity, oral Category 3 Sensitization, respiratory Category 1 Sensitization, skin Category 1 Specific target organ toxicity, single exposure Category 2 (liver, kidneys) Specific target organ toxicity, single exposure Category 3 narcotic effects Specific target organ toxicity, repeated Category 2 (liver) exposure
Environmental hazards
Environmental hazards Not classified. OSHA OSHA defined defined defined hazards Not classified.
Contains
ACETAMINOPHEN, HYDROXYPROPYL CELLULOSE, OXYCODONE HYDROCHLORIDE, POLYETHYLENE OXIDE Label
2.2 Label elements
elements
Signal word
Signal word Danger
Hazard statements
Hazard statement Narcotic. Toxic if swallowed. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction. May cause damage to organs (liver, kidneys). May cause drowsiness or dizziness. May cause damage to organs (liver) through prolonged or repeated exposure. Precautionary
Prevention
Do not breathe dust/fume. Use only outdoors or in a well-ventilated area. In case of inadequate ventilation wear respiratory protection. Do not eat, drink or smoke when using this product. Wear protective gloves. Wash thoroughly after handling. Contaminated work clothing must not be allowed out of the workplace.
Response
If swallowed Immediately call a poison center/doctor. Rinse mouth. If on skin Wash with plenty of water. If skin irritation or rash occurs Get medical advice/attention. If inhaled Remove person to fresh air and keep comfortable for breathing. If experiencing respiratory symptoms: Call a poison center/doctor. Get medical advice/attention if you feel unwell. Wash contaminated clothing before reuse.
Storage
Store in a well-ventilated place. Keep container tightly closed. Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) Hazard(s) not not not otherwise otherwise None known.
Classified (HNOC)
classified (HNOC)
Additional information
Supplemental information The hazard warnings associated with this product are based on the individual ingredients included in the finished dosage form of the pharmaceutical product. The supplied package insert (approved labeling) provides the necessary drug safety information. As per 29 CFR 1910.1200(b)(5)(iii), any food, food additive, color additive, drug, cosmetic, or medical or veterinary device or product, including materials intended for use as ingredients in such products (e.g. flavors and fragrances), as such terms are defined in the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and regulations issued under that Act, when they are subject to the labeling requirements under that Act by the Food and Drug Administration are exempted from the requirements of the Hazard Communication Standard. All Mallinckrodt finished products are labeled in compliance with the requirements of the Food and Drug Administration (FDA) and must be used in the prescribed manner. Each package of the finished pharmaceutical product is supplied with a package insert (approved labeling) which provides necessary drug safety information. 3. 3. 3. 3. Composition/information